Cargando…

Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital()

BACKGROUND: Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccines have been approved recently, and public concern regarding the risk of anaphylactic reactions arose after a few cases during the first days of mass vaccination. Polyethylene glycol (PEG) has been suggested as the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paoletti, Giovanni, Racca, Francesca, Piona, Alessandra, Melone, Giulio, Merigo, Morena, Puggioni, Francesca, Ferri, Sebastian, Azzolini, Elena, Lagioia, Michele, Lamacchia, Donatella, Cataldo, Giuseppe, Cecconi, Maurizio, Canonica, Giorgio Walter, Heffler, Enrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8030995/ https://www.ncbi.nlm.nih.gov/pubmed/33850601 http://dx.doi.org/10.1016/j.waojou.2021.100541

Ejemplares similares

Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model
por: Malipiero, Giacomo, et al.
Publicado: (2020)

Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines
por: Nappi, Emanuele, et al.
Publicado: (2023)

An academic allergy unit during COVID-19 pandemic in Italy
por: Malipiero, Giacomo, et al.
Publicado: (2020)

The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital
por: Paoletti, Giovanni, et al.
Publicado: (2023)

Nasal Polyposis Quality of Life (NPQ): Development and Validation of the First Specific Quality of Life Questionnaire for Chronic Rhinosinusitis with Nasal Polyps
por: Baiardini, Ilaria, et al.
Publicado: (2022)

Interleukin-5 in the Pathophysiology of Severe Asthma
por: Pelaia, Corrado, et al.
Publicado: (2019)

Extended IgE profile based on an allergen macroarray: a novel tool for precision medicine in allergy diagnosis
por: Heffler, Enrico, et al.
Publicado: (2018)

Desensitization Protocols for Anti-SARS-CoV-2 Vaccines in Patients with High Risk of Allergic Reactions
por: Messina, Maria Rita, et al.
Publicado: (2023)

A critical appraisal on AIT in childhood asthma
por: Ferrando, Matteo, et al.
Publicado: (2018)

Immunostimulants in respiratory diseases: focus on Pidotimod
por: Puggioni, Francesca, et al.
Publicado: (2019)

Community pharmacist’s professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists
por: Giua, Corrado, et al.
Publicado: (2021)

Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets
por: Racca, Francesca, et al.
Publicado: (2022)

Choosing wisely in Allergology: a Slow Medicine approach to the discipline promoted by the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)
por: Heffler, Enrico, et al.
Publicado: (2015)

Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients
por: Brunetta, Enrico, et al.
Publicado: (2018)

Mast Cells in Upper and Lower Airway Diseases: Sentinels in the Front Line
por: Costanzo, Giovanni, et al.
Publicado: (2023)

Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps
por: Paoletti, Giovanni, et al.
Publicado: (2022)

Artificial intelligence processing electronic health records to identify commonalities and comorbidities cluster at Immuno Center Humanitas
por: Morandini, Pierandrea, et al.
Publicado: (2022)

Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
por: Puggioni, Francesca, et al.
Publicado: (2020)

Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI
por: Senna, Gianenrico, et al.
Publicado: (2020)

New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine
por: Nappi, Emanuele, et al.
Publicado: (2022)

Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis
por: Di Bona, Danilo, et al.
Publicado: (2021)

Cross-Cultural Validation of the Short Version of the Questionnaire of Olfactory Disorders—Negative Statements into Italian: Towards Personalized Patient Care
por: Pirola, Francesca, et al.
Publicado: (2022)

Oral Corticosteroid Abuse and Self-Prescription in Italy: A Perspective from Community Pharmacists and Sales Reports before and during the COVID-19 Era
por: Nappi, Emanuele, et al.
Publicado: (2023)

Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)
por: Heffler, Enrico, et al.
Publicado: (2020)

Care for Patients with Type-2 Chronic Rhinosinusitis
por: Giunta, Gianmarco, et al.
Publicado: (2023)

The North-Western Italian experience with anti IL-5 therapy amd comparison with regulatory trials
por: Bagnasco, Diego, et al.
Publicado: (2018)

The Present and Future of Allergen Immunotherapy in Personalized Medicine
por: Ridolo, Erminia, et al.
Publicado: (2022)

Use, Abuse, and Misuse of Nasal Medications: Real-Life Survey on Community Pharmacist’s Perceptions
por: Russo, Elena, et al.
Publicado: (2023)

Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis
por: Heffler, Enrico, et al.
Publicado: (2020)

Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria
por: Folci, Marco, et al.
Publicado: (2018)

Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma
por: Bagnasco, Diego, et al.
Publicado: (2017)

Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience
por: Varricchi, Gilda, et al.
Publicado: (2016)

Critical evaluation of asthma biomarkers in clinical practice
por: Guida, Giuseppe, et al.
Publicado: (2022)

History of the World Allergy Organization: Innovation in Continuity 2008–2009
por: Canonica, Giorgio Walter
Publicado: (2011)

Ragweed allergy: Pollen count and sensitization and allergy prevalence in two Italian allergy centers
por: Ariano, Renato, et al.
Publicado: (2015)

Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs
por: Varricchi, Gilda, et al.
Publicado: (2016)

Personalized Approach to Severe Asthma
por: Heffler, Enrico, et al.
Publicado: (2018)

Biologics and airway remodeling in severe asthma
por: Varricchi, Gilda, et al.
Publicado: (2022)

Antioxidant potential of the diet in Italian children with food allergies
por: Pendezza, Erica, et al.
Publicado: (2023)

Prevalence of familial link in patients affected by chronic rhinosinusitis with nasal polyposis
por: Giombi, Francesco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5u5sm6rsru34inp3lprefrj43c